Pluri Inc. Operating Lease, Weighted Average Discount Rate, Percent
Pluri Inc. (PLUR) had Operating Lease, Weighted Average Discount Rate, Percent of 13.00% as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-09-10
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 13.00%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.00%.
- 2024-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.00%.
- 2023-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 13.00% 10-K · filed 2026-09-10 |
| 2025-06-30 | 9.00% 10-K · filed 2026-09-10 |
| 2024-06-30 | 9.00% 10-K · filed 2025-09-17 |
| 2023-06-30 | 9.00% 10-K · filed 2024-09-18 |
| 2022-06-30 | 9.00% 10-K · filed 2023-09-12 |
| 2021-06-30 | 10.00% 10-K · filed 2021-09-13 |
| 2020-06-30 | 10.00% 10-K · filed 2020-09-10 |
| 2020-03-31 | 10.00% 10-Q · filed 2020-05-11 |
| 2019-12-31 | 10.00% 10-Q · filed 2020-02-06 |
| 2019-09-30 | 10.00% 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |